Skip to main navigation
Ocular Therapeutix, Inc. Home page
Ocular Therapeutix Logo
  • Compliance
  • Contact
  • Therapeutic Areas
    • Retinal Diseases
    • Glaucoma
    • Ophthalmic Surgery
  • Pipeline
    • Our Ophthalmology Pipeline
    • AXPAXLI™ (axitinib intravitreal implant)
    • PAXTRAVA™ (travoprost intracameral implant)
    • Clinical Trials
  • Technology
    • ELUTYX™ Technology
    • Partnership Opportunities
  • Products
    • DEXTENZA® (dexamethasone ophthalmic insert)
    • ReSure® Sealant
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • Investor FAQs
    • Email Alerts
  • About
    • Company Overview
    • Board of Directors
    • Management Team
    • Global Scientific Advisory Board
  • Careers
    • Benefits
    • Culture and Values
    • Diversity, Equity & Inclusion
    • Open Positions
BreadcrumbHome / Investors / SEC Filings / SEC Filing Details

SEC Filing Details

Jump Links - All Pages
OverviewPress ReleasesEvents and PresentationsSEC FilingsCorporate GovernanceStock Information

Document Details

Form
CT ORDER
Filing Date
August 30, 2016
Document Date
August 30, 2016
Form Description
CT ORDER
Filing Group
Other
Company
Ocular Therapeutix, Inc.
Issuer
OCULAR THERAPEUTIX, INC

Filing Formats

Download PDF

Additional Resources

Investor FAQs
Information Request
Ocular Therapeutix Logo
  • Therapeutic Areas
    • Retinal Diseases
    • Glaucoma
    • Ophthalmic Surgery
  • Pipeline
    • Our Ophthalmology Pipeline
    • AXPAXLI™
    • PAXTRAVA™
    • Clinical Trials
  • Technology
    • ELUTYX™ Technology
    • Partnership Opportunities
  • Products
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • Investor FAQs
    • Email Alerts
  • About
    • Company Overview
    • Management Team
    • Board of Directors
    • Global Advisory Scientific Board
  • Careers
    • Benefits
    • Culture and Values
    • Diversity, Equity & Inclusion
    • Open Positions
  • Linkedin
  • X
© 2024 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA and ReSure are registered trademarks and ELUTYX, AXPAXLI, and PAXTRAVA are trademarks of Ocular Therapeutix, Inc.
Footer Copyright Links
  • Terms of Use
  • Privacy Policy
  • Compliance
  • Site Map
  • PP-US-OTX-0024